Data as of 10:51am ET
| -0.28 / -2.25%|
The 1 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a -34.32% decrease from the last price of 12.18.
The current consensus among 1 polled investment analysts is to Hold stock in Ocera Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.